<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00806689</url>
  </required_header>
  <id_info>
    <org_study_id>08-046</org_study_id>
    <nct_id>NCT00806689</nct_id>
  </id_info>
  <brief_title>Full Disclosure Observational Cardiac Rhythm Documentation Follow-up After Surgical Atrial Fibrillation Therapy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Luebeck</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Luebeck</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      24 hour Holter monitoring (24HM) is commonly used to assess cardiac rhythm after surgical
      therapy of atrial fibrillation. This &quot;snapshot&quot; rhythm documentation leaves a large
      diagnostic window of non recorded atrial arrhythmias and as such a large amount of
      uncertainty in follow-up result assessment. To improve accuracy of rhythm surveillance thus
      gaining a more &quot;real-life&quot; scenario of post surgical ablation therapy cardiac rhythm a new
      insertable cardiac rhythm monitor device (Reveal速 XT 9525, Medtronic Inc., Minneapolis, MN,
      USA) with full observational continuous heart rhythm documentation is implanted.

      In order to verify different follow-up strategies after surgical atrial fibrillation therapy,
      a comparison of different follow-up scenarios (symptoms, different cardiac documentation
      devices i.e. ECG and 24 hour Holter monitor, at different follow-up time points) is performed
      intraindividually. Thus the reliability of these devices and follow-up strategies to define
      success after ablation therapy is evaluated.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2007</start_date>
  <completion_date type="Anticipated">July 2011</completion_date>
  <primary_completion_date type="Anticipated">December 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>Atrial fibrillation burden development after surgical ablation therapy</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of different cardiac rhythm documentation strategies to define success after ablation therapy</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Cardiac surgery patients</arm_group_label>
    <description>Patients in atrial fibrillation being scheduled for cardiac surgery and concomitant ablation procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cardiac rhythm monitor implantation</intervention_name>
    <description>post surgical procedure implantation of insertable event recorder for long time heart rhythm surveillance afte ablation therapy</description>
    <arm_group_label>Cardiac surgery patients</arm_group_label>
    <other_name>Reveal速 XT 9525, Medtronic Inc., Minneapolis, MN, USA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Reveal速 XT 9525</intervention_name>
    <description>During cardiac surgery after stand alone or concomitant ablation procedure, an insertable loop recorder will be implanted subcutaneously in left pectoral region. After surgery, patients will be monitored regularly in a quarterly basis by performing telemetry of the device in the outpatient clinic. Furthermore, home telemetry will be performed once a month for optimal heart rhythm observation.</description>
    <arm_group_label>Cardiac surgery patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients who are scheduled for cardiac surgery and who also present with any kind of atrial
        fibrillation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients in atrial fibrillation (AF duration &gt;4 months)being scheduled for cardiac
             surgery

          -  patients with lone atrial fibrillation being scheduled for surgical AF treatment

        Exclusion Criteria:

          -  failure to provide informed consent

          -  current participation in another clinical trial

          -  organic cause of atrial fibrillation (hyperthyroidism etc.)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hans-H. Sievers, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Clinic for Cardiac and Thoracic Vascular Surgery, University of Luebeck, germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thorsten Hanke, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinic for Cardiac and Thoracic Vascular Surgery, University of Luebeck, germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ulrich Stierle, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Clinic for Cardiac and Thoracic Vascular Surgery, University of Luebeck, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thorsten Hanke, MD</last_name>
    <phone>0049-451-500</phone>
    <phone_ext>2108</phone_ext>
    <email>Thorsten.Hanke@uk-sh.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinic for Cardiac and Thoracic Vascular Surgery, University of L端beck, Germany</name>
      <address>
        <city>Luebeck</city>
        <state>Schleswig-Holstein</state>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans-H. Sievers, M.D.</last_name>
      <phone>0049451500</phone>
      <phone_ext>2108</phone_ext>
      <email>h.sievers@herzchirurgie-luebeck.de</email>
    </contact>
    <contact_backup>
      <last_name>Thorsten Hanke, M.D.</last_name>
      <phone>0049451500</phone>
      <phone_ext>2108</phone_ext>
      <email>Thorsten.Hanke@uk-sh.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Hanke T, Charitos EI, Stierle U, Karluss A, Kraatz E, Graf B, Hagemann A, Misfeld M, Sievers HH. Twenty-four-hour holter monitor follow-up does not provide accurate heart rhythm status after surgical atrial fibrillation ablation therapy: up to 12 months experience with a novel permanently implantable heart rhythm monitor device. Circulation. 2009 Sep 15;120(11 Suppl):S177-84. doi: 10.1161/CIRCULATIONAHA.108.838474.</citation>
    <PMID>19752365</PMID>
  </results_reference>
  <verification_date>December 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 10, 2008</study_first_submitted>
  <study_first_submitted_qc>December 10, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2008</study_first_posted>
  <last_update_submitted>July 1, 2010</last_update_submitted>
  <last_update_submitted_qc>July 1, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 2, 2010</last_update_posted>
  <responsible_party>
    <name_title>Prof. Dr. med. Hans-H. Sievers</name_title>
    <organization>Clinic for Cardiac and Thoracic Vascular Surgery, University of Luebeck</organization>
  </responsible_party>
  <keyword>heart rhythm surveillance</keyword>
  <keyword>follow-up</keyword>
  <keyword>atrial fibrillation success</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

